SEARL Secures Approval For Locally Manufactured Biosimilar Drug
SEARL aims to provide high-quality, cost-effective biotechnology medicines to patients in Pakistan, addressing critical healthcare needs. The Searle Company Limited…
SEARL aims to provide high-quality, cost-effective biotechnology medicines to patients in Pakistan, addressing critical healthcare needs. The Searle Company Limited…
Neurodegenerative disorders, affecting millions of people in the United States, incur significant financial costs for care, amounting to hundreds of…
The rising popularity of these weight-loss drugs, driven by media exposure and high demand, has made them a prime target…
Antibiotic resistance is a global issue that requires international collaboration. Countries must work together to combat resistance and share data…
Ginger and garlic are two items that can be used in many different ways and have always been appealing. These…
Arialys Therapeutics has secured $58 million in seed funding for the development of treatments targeting autoimmune neuropsychiatric diseases. Arialys Therapeutics,…
This groundbreaking partnership signifies a monumental leap forward in the pursuit of innovative and curative treatments for a range of…
The company’s mission is to improve the lives of people with bladder health problems by providing them with personalized care…
The climate crisis is also expected to make mosquito transmission more difficult in the future, similar to the worsening of…
Through MyStartr, DrPrevents, a Malaysian provider of preventive healthcare services, will begin its first Equity Crowdfunding (ECF) campaign. Through MyStartr,…
A new study founds a combination of immunotherapy and targeted therapy may be more effective than immunotherapy alone in advanced…
According to the WHO, more than 87,000 confirmed cases of mpox have been detected globally since the beginning of last…